Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Sorrento Therapeutics Inc

CUSIP: 83587F902 | 11 institutional holders

Quarters

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile